|
Q4 FY2026
As of Jun 27, 2026
|
Q3 FY2026
As of Mar 28, 2026
|
Q2 FY2026
As of Dec 27, 2025
|
Q1 FY2026
As of Sep 27, 2025
|
Q4 FY2025
As of Jun 28, 2025
|
Q3 FY2025
As of Mar 29, 2025
|
Q2 FY2025
As of Dec 28, 2024
|
Q1 FY2025
As of Sep 28, 2024
|
Q4 FY2024
As of Jun 29, 2024
|
Q3 FY2024
As of Mar 30, 2024
|
Q2 FY2024
As of Dec 30, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jul 1, 2023
|
Q3 FY2023
As of Apr 1, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Oct 1, 2022
|
Q4 FY2022
As of Jul 2, 2022
|
Q3 FY2022
As of Apr 2, 2022
|
Q2 FY2022
As of Jan 1, 2022
|
Q1 FY2022
As of Oct 2, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable, less allowances of $71.4 and $69.0 | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Income taxes receivable | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Trade accounts payable and outstanding checks in excess of deposits | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Finance lease obligations—current installments | ||||||||||||||||||||
| Operating lease obligations—current installments | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Deferred income tax liability, net | ||||||||||||||||||||
| Finance lease obligations, excluding current installments | ||||||||||||||||||||
| Operating lease obligations, excluding current installments | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Common Stock: $0.01 par value per share, 1.0 billion shares authorized, 156.1 million shares issued and outstanding as of June 27, 2026; 154.9 million shares issued and outstanding as of June 28, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of tax benefit of $1.1 and $0.9 | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
